SCHEMBL875417

SCHEMBL875417

CCCCOc1cccc(O)c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 1/20 0.64
CHRNA4 P43681 1/20 0.64
MEN1 O00255 1/20 0.57
NPC1 O15118 1/20 0.57
ALDH1A1 P00352 1/20 0.57
GAA P10253 1/20 0.57
MAPT P10636 1/20 0.57
RAB9A P51151 1/20 0.57
KMT2A Q03164 1/20 0.57
L3MBTL1 Q9Y468 1/20 0.57
LTA4H P09960 4/20 0.56
NR5A1 Q13285 1/20 0.56
TSHR P16473 1/20 0.54
DRD2 P14416 1/20 0.51
DRD4 P21917 1/20 0.51
ADRA1D P25100 1/20 0.51
ADRA1A P35348 1/20 0.51
ADRA1B P35368 1/20 0.51
DRD3 P35462 1/20 0.51
THRB P10828 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29378187 1.00 CHRNB2 (0.64) CHRNB2CHRNA4MEN1NPC1ALDH1A1
Resorcinol SCHEMBL11140044 0.98 CHRNB2 (0.62) CHRNB2CHRNA4MEN1NPC1ALDH1A1
Benzene SCHEMBL28002836 0.98 CHRNB2 (0.62) CHRNB2CHRNA4MEN1NPC1ALDH1A1
SCHEMBL3636219 0.94 CHRNB2 (0.62) CHRNB2CHRNA4MEN1NPC1ALDH1A1
SCHEMBL22207445 0.93 TSHR (0.65) CHRNB2CHRNA4LTA4HNR5A1TSHR
SCHEMBL22207466 0.93 TSHR (0.65) CHRNB2CHRNA4LTA4HNR5A1TSHR
SCHEMBL22207358 0.93 TSHR (0.65) CHRNB2CHRNA4LTA4HNR5A1TSHR
SCHEMBL22207094 0.93 TSHR (0.65) CHRNB2CHRNA4LTA4HNR5A1TSHR
SCHEMBL7259108 0.93 TSHR (0.65) CHRNB2CHRNA4LTA4HNR5A1TSHR
SCHEMBL9717882 0.93 TSHR (0.65) CHRNB2CHRNA4LTA4HNR5A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1414 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260047990-A1 Compositions and Methods for Treating Skin Discoloration RACQUEL FRISELLA LLC (US) 2026-02-19 US claimed
CN-116693727-B Catalyst for olefin polymerization and application thereof 中国石油化工股份有限公司 2025-05-06 CN claimed
CN-116693728-B Solid catalyst component, preparation method thereof, olefin polymerization catalyst and application thereof 中国石油化工股份有限公司 2025-05-06 CN claimed
CN-119632866-A Polygonum cuspidatum glycoside composition with effects of whitening skin, removing freckles and eliminating jaundice and preparation method thereof 赣州华汉生物科技有限公司 2025-03-18 CN claimed
CN-116606390-B Olefin polymerization catalyst and application thereof 中国石油化工股份有限公司 2025-01-07 CN claimed
CN-118986754-A Stem cell culture supernatant flexible liposome, preparation method and application thereof in skin younger products 小草生物科技有限公司 2024-11-22 CN claimed
CN-114790266-B Tyrosine-based thermosetting phenolic resin with anti-biological adhesion function and preparation method and application thereof 烟台哈尔滨工程大学研究院 2024-11-19 CN claimed
CN-116606391-B Olefin polymerization catalyst solid component, preparation method thereof, olefin polymerization catalyst and application 中国石油化工股份有限公司 2024-11-19 CN claimed
US-20240350378-A1 DEODORANT COSMETIC PRODUCT JOBAN BEAUTY, INC. (US) 2024-10-24 US claimed
US-12053537-B2 Reduction of stinging sensation on skin SYMRISE AG (DE) 2024-08-06 US claimed
CN-1274759-C Weatherability type polyformaldehyde material and its preparation method UNIV SICHUAN (CN) 2006-09-13 CN claimed
US-20060040847-A1 Hard surface treating compositions RECKITT BENCKISER INC. 2006-02-23 US claimed
WO-2005107456-A2 ANTIMICROBIAL SILICON OXIDE FLAKES CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2005-11-17 WO claimed
EP-1537201-A1 HARD SURFACE TREATING COMPOSITIONS Reckitt Benckiser Inc. (US) 2005-06-08 EP claimed
CN-1618872-A Weatherability type polyformaldehyde material and its preparation method UNIV SICHUAN (CN) 2005-05-25 CN claimed
EP-0805672-B1 METHODS, COMPOSITIONS, AND DENTAL DELIVERY SYSTEMS FOR THE PROTECTION OF THE SURFACES OF TEETH HOMOLA ANDREW M (US) 2004-08-25 EP claimed
WO-2004024861-A1 HARD SURFACE TREATING COMPOSITIONS RECKITT BENCKISER INC (US) 2004-03-25 WO claimed
US-5665333-A Methods, compositions, and dental delivery systems for the protection of the surfaces of teeth PROVSEAL LLC 1997-09-09 US claimed
EP-0687249-A1 BALANOIDS ELI LILLY AND COMPANY (US) 1995-12-20 EP claimed
WO-1994020062-A2 BALANOIDS AS PROTEIN KINASE C INHIBITORS ELI LILLY AND COMPANY (US) 1994-09-15 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260047990-A1 Compositions and Methods for Treating Skin Discoloration TYR, TH, DYRK1A CHRNB2 3901/4885CHRNA4 4153/4885MEN1 4049/4885
US-12053537-B2 Reduction of stinging sensation on skin STING1, TYR, CUTA CHRNB2 317/4885CHRNA4 515/4885MEN1 1463/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.